TMEM225B: A Drug Target / Disease Biomarker (G100289187)

Target Name: TMEM225B

NCBI ID: G100289187

TMEM225B

TMEM225B: A Drug Target / Disease Biomarker

TMEM225B, also known as heat shock protein 90 (Hsp90), is a protein that is expressed in a variety of tissues throughout the body. It is a key regulator of protein stability and localization, and has been implicated in a number of cellular processes. In recent years, researchers have been interested in studying TMEM225B as a potential drug target or biomarker, due to its unique biology and its potential role in a variety of diseases.

TMEM225B is a heat shock protein that is expressed in a variety of tissues, including the brain, heart, liver, and kidney. It is a member of the Hsp90 family, which includes a number of proteins that are involved in the regulation of protein stability and localization. Hsp90 proteins are highly resistant to various forms of stress, including temperature, pH, and storage conditions, and are thought to play a key role in protecting cells from these types of stressors.

One of the unique features of TMEM225B is its ability to interact with a variety of different proteins. This is due to the fact that TMEM225B is a protein that is highly conserved, and as such, it has a number of known interactions with other proteins. These interactions can be either positive or negative, and can affect the stability or localization of TMEM225B. For example, some studies have shown that TMEM225B can interact with stress-responsive proteins, such as heat shock proteins (HSPs) andperpapillary actinin (PPi), to help regulate their stability and localization.

Another important function of TMEM225B is its role in the regulation of protein stability. TMEM225B is thought to play a key role in the regulation of protein stability by affecting the stability of its own protein subunits. This can happen through a variety of different mechanisms, including the formation of inclusion domains or the regulation of the activity of enzymes involved in protein synthesis.

In addition to its role in protein stability, TMEM225B is also involved in a number of other cellular processes. For example, it has been shown to be involved in the regulation of cell adhesion, and in the regulation of cell signaling pathways. In addition, TMEM225B has also been shown to play a role in the regulation of inflammation and immune response.

As a potential drug target, TMEM225B is due to its unique biology and its potential role in a variety of diseases. Because it is a protein that is involved in a number of different cellular processes, it is a promising target for the development of new drugs that can treat a wide range of diseases. In addition, because TMEM225B is highly conserved, it is relatively easy to use for drug screening and validation studies.

In conclusion, TMEM225B is a protein that is expressed in a variety of tissues throughout the body and is involved in a number of different cellular processes. It is a potential drug target due to its unique biology and its potential role in a variety of diseases. Further research is needed to fully understand the role of TMEM225B in the regulation of protein stability and localization, and to develop new drugs that can target this protein.

Protein Name: Transmembrane Protein 225B

The "TMEM225B Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TMEM225B comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets